Back to Browse Journals » Open Access Journal of Contraception » Volume 3

Obesity and contraception: controversy?

Authors Goldberg RD, Cardamone SC, Murthy AS

Published Date January 2012 Volume 2012:3 Pages 1—8

DOI http://dx.doi.org/10.2147/OAJC.S17405

Received 21 July 2011, Accepted 12 September 2011, Published 10 January 2012

Rebecca D Goldberg, Stefanie C Cardamone, Amitasrigowri S Murthy
Department of Obstetrics and Gynecology, New York University School of Medicine, New York, NY, USA

Abstract: Obesity is increasing worldwide and is affecting the reproductive health of women. Contraceptive considerations are difficult in obese women given concerns about efficacy and comorbid conditions. Once surgical treatment of obesity has occurred and weight loss initiated, fertility risks increase and unintended pregnancy can result; often at the time of greatest weight loss. Family planning counseling in the obese patient must account for both preoperative conditions as well as postoperative return to fertility.

Keywords: obesity, contraception, bariatric surgery

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Pharmacokinetics and pharmacodynamics of acetylsalicylic acid after intravenous and oral administration to healthy volunteers

Nagelschmitz J, Blunck M, Kraetzschmar J, Ludwig M, Wensing G, Hohlfeld T

Clinical Pharmacology: Advances and Applications 2014, 6:51-59

Published Date: 19 March 2014

Population pharmacokinetics of olprinone in healthy male volunteers

Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H

Clinical Pharmacology: Advances and Applications 2014, 6:43-50

Published Date: 4 March 2014

An update on the potential for male contraception: emerging options

Garside DA, Gebril A, Alsaadi M, Nimmo N, Mullen AB, Ferro VA

Open Access Journal of Contraception 2013, 4:1-11

Published Date: 11 April 2013

Oral contraception and risk of endometrial cancer

Mueck AO, Seeger H, Ruan X

Open Access Journal of Contraception 2011, 2:127-136

Published Date: 18 October 2011

Detemir as a once-daily basal insulin in type 2 diabetes

Nelson SE

Clinical Pharmacology: Advances and Applications 2011, 3:27-37

Published Date: 18 August 2011